Title:
腫瘍マーカー、メチル化検出試薬、キット及びその使用
Document Type and Number:
Japanese Patent JP7123177
Kind Code:
B2
Abstract:
The present invention falls within the field of biotechnology, and a tumor marker, a methylation detection reagent, a kit and the use thereof are disclosed. Disclosed in the present invention is that: colorectal cancer specimens can be distinguished from normal human fecal specimens by detecting the methylation level of COL4A2 gene promoter region. The present invention uses a methylation detection reagent of the gene to detect colorectal cancer.
Inventors:
Liu Sorin
Zhao Shun
Zou Hongzhi
Zhao Shun
Zou Hongzhi
Application Number:
JP2020565479A
Publication Date:
August 22, 2022
Filing Date:
May 05, 2019
Export Citation:
Assignee:
Guangzhou Kangling Ming Biotechnology Co., Ltd.
International Classes:
C12N15/12; C12M1/34; C12Q1/68; C12Q1/6886
Domestic Patent References:
| JP2013545437A |
Foreign References:
| WO2011002029A1 |
Other References:
BMC Cancer,2014年,14:54,1-15
Attorney, Agent or Firm:
Yoshiyuki Inaba
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito
Previous Patent: Vinyl chloride polymer and its production method
Next Patent: TELEPHONE TERMINAL EQUIPMENT
Next Patent: TELEPHONE TERMINAL EQUIPMENT